ABOUT US
With a rich heritage dating back hundreds of years, Cytiva brings a wealth of technical expertise and talent, a broad and deep portfolio, and exceptional service help researchers and biopharma advance therapeutics at every stage from discovery to delivery.
We supply the tools and support our customers need to work better, faster, and safer, leading to the delivery of transformative medicines to patients. Our combined portfolio includes well-recognized names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™. Visit cytiva.com to learn more.
VIDEOS
WEBINARS
BROCHURES AND DATASHEETS
- Advanced Automation System For Flexible Aseptic Filling
- Bioreactors Designed For Cell Growth And Expansion
- Antibody Production: Scale-Up Menu
- Allegro MVP Single-Use System
- An IoT Solution For A Reliable, Real-Time Informed Diagnosis
- A Flexible Service Model With Rapid Response And Access To Knowledge
- Online Service Solutions For Optimal Performance Of Your Instruments
- Single‑Use Filtration System For Pilot‑ And Small‑Scale Manufacturing
- A Ready-To-Use, Single-Use Liquid Chromatography System
- Mechanistic Chromatography Modeling To Accelerate Process Development
APPLICATION NOTES
- Balancing Protein A Resin Cost, Performance, And Productivity
- Optimizing TFF And SPTFF For High-Concentration mAb Formulations
- Selecting A Platform Filter For High Concentration mAbs
- Production Of A Highly Concentrated Monoclonal Antibody
- Extractables In Single-Use Systems Used In ADC Manufacturing
- Adapting Single-Use Chromatography To Manufacturing Scale
- Developing A Large-Scale Tangential Flow Filtration Process
- Bulk Filling Of Drug Substance | Accurate Aliquoting
- Sterilizing Grade Filter Performance With Biologic Drugs
- Developing A HIC Polishing Step For The Removal Of mAb Aggregates
CONTACT INFORMATION
Cytiva
100 Results Way
Marlborough, MA 08855-1327
UNITED STATES
Phone: 800-526-3593
FEATURED ARTICLES
-
Biopharma’s future depends on collaboration. Discover how cross-industry partnerships and shared resources can accelerate innovation, overcome talent gaps, and strengthen the global R&D ecosystem.
-
Cell therapy’s future depends on smarter gene delivery. Learn how lipid nanoparticles offer a scalable, cell-friendly alternative to electroporation and viral vectors for manufacturing efficiency.
-
Biopharma is innovating fast but falling short commercially. Reveal key ecosystem gaps and five strategic actions to help strengthen resilience, accelerate performance, and futureproof organizations.
-
With many blockbuster drug patents set to expire by 2030, the market is ripe for biosimilar developers to stake their claim. To succeed, they must be strategic and compliant.
-
PFAS restrictions are tightening, but a full ban could disrupt critical industries lacking alternatives, such as pharmaceutical manufacturing. Learn where PFAS use remains indispensable.
-
Forever chemicals pose rising health risks and regulatory challenges. Learn how increasing restrictions on fluorinated compounds could reshape manufacturing, packaging, and sustainability strategies.
-
The biosimilar patent cliff is reshaping pharma, creating unprecedented opportunities for biotech and CDMOs. Explore expert regulatory support that can help you navigate this shift with confidence.
-
Discover how early intervention in ADC development can streamline clinical progress, ensure stability and safety, and accelerate commercialization with expert guidance.
-
Explore aseptic filling workcells, modalities, agency approvals, and insights from six expert users that offer a peer-driven look at industry innovation and benchmarks.
-
Explore how a partnership with UW–Madison and Genentech developed a breakthrough recycling technology that is poised to reshape single-use bioprocessing sustainability.